| Keywords: |
immunohistochemistry; cancer chemotherapy; treatment outcome; fludarabine; prednisone; review; doxorubicin; interferon; cancer radiotherapy; methotrexate; cancer staging; flow cytometry; alkylating agent; cyclophosphamide; immunoglobulin; practice guideline; recurrent infection; stem cell transplantation; vincristine sulfate; lymphoma, b-cell; nonhodgkin lymphoma; bone marrow biopsy; lymphoma, non-hodgkin; asparaginase; immunophenotyping; beta 2 microglobulin; physical examination; cancer classification; chronic lymphatic leukemia; databases, factual; endoscopy; stomach neoplasms; lymphoma, follicular; cytopenia; lymphocytoma; omeprazole; practice guidelines; leukemia, lymphocytic, chronic; stomach lymphoma; lymphoma, large-cell, diffuse; anthracycline antibiotic agent; lymphoma, mucosa-associated lymphoid tissue; humans; lymphoma, small-cell
|
